Today: 16 April 2026
Westpac shares slide after RBA turns “live” and GDP surprise lifts rate bets
4 March 2026
1 min read

Westpac shares slide after RBA turns “live” and GDP surprise lifts rate bets

Sydney, March 4, 2026, 17:21 (AEDT) — The session has ended.

  • Westpac slipped 1.9%, with investors reacting to new RBA signals that pointed to a steeper rate trajectory.
  • Australia’s Q4 GDP topped forecasts, leaving inflation concerns on the table.
  • Attention shifts to the RBA’s March 17 decision, with Westpac’s reporting dates also drawing near.

Westpac Banking Corp shares slipped on Wednesday. The Reserve Bank of Australia hinted at a possible move in March, while fresh data revealed the economy ran hotter than anticipated late last year.

Westpac slipped A$0.81 to finish at A$40.99, marking a 1.9% drop from Tuesday’s close. The stock trailed behind other names tied to rates, as the mood stayed cautious.

Markets reacted quickly after RBA Governor Michele Bullock flagged a change in approach, saying during a Sydney event this week that each policy meeting is now “live” and a rate move could come as soon as March if inflation expectations threaten to drift. Reuters

The timing coincided with a stronger-than-expected performance from Australia’s economy. Reuters reported gross domestic product rose 0.8% in the December quarter, up 2.6% from a year earlier—a clip that could complicate efforts to tamp down inflation, despite consumers remaining wary.

Higher rates may give bank stocks a lift on interest income, but it’s never straightforward. Investors keep a close eye on how tighter policy hits credit demand, mortgage strain, and bad-debt costs—particularly following a strong rally that’s left scant margin for letdowns.

Bullock flagged supply-shock risks from the Middle East conflict, saying those pressures could rattle inflation via energy prices.

Westpac steps into the spotlight, with investors eyeing its half-year finish on March 31. Interim results and the all-important dividend call are slated for May 5.

Westpac’s listed hybrids are on the radar for certain investors, especially with a handful of capital notes set to pay out distributions on March 23.

Traders in the sector usually keep an eye on the other big players—Commonwealth Bank, ANZ, and National Australia Bank—looking for moves in funding costs, asset quality, or shifts in home loan competition that might point to broader changes.

Macro moves are still driving the action. With growth showing some muscle, speculation around the RBA sticks around — bank stocks usually ride that discussion from one session to the next.

Westpac bulls face two big risks: a rapid tightening could trigger a sector-wide valuation reset, or sluggish borrowers might buckle under heftier repayments—sending impairment charges north from their current lows.

Now attention shifts to the RBA’s March 17 call, with traders set to find out if “live” signals an actual move or simply a shot across the bow. Reuters

Stock Market Today

  • Amerigo Resources Q1 2026 Results Signal Capital Allocation Shift with Dividend and Buyback
    April 15, 2026, 9:21 PM EDT. Amerigo Resources Ltd. (TSX:ARG) reported Q1 2026 operating results reaffirming full-year copper and molybdenum production guidance. The company completed a C$5.9 million share buyback and declared a C$0.16 per-share performance dividend payable in May 2026. Despite scheduled maintenance, cash costs trended below guidance, highlighting operational efficiency. Amerigo's single-asset strategy focuses on cash generation and capital returns, underscored by this combination of buyback and special dividend. Shares have risen but appear undervalued by roughly 30% against fair value estimates ranging from C$5.26 to C$9.15. However, recent insider selling adds risk. The firm's capital discipline and market positioning suggest investors watch copper prices, MVC execution, and future capital decisions closely.

Latest article

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

16 April 2026
Norse Atlantic Airways has canceled all planned summer flights from Los Angeles to London Gatwick, Paris, and Rome, citing surging jet fuel costs. The airline launched a $110 million rights issue, secured a $70 million bridge loan, and withdrew its 2026 outlook. Routes disappeared from booking systems on April 14. Norse had been the only scheduled operator on the Gatwick-Los Angeles route.
S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

16 April 2026
The S&P 500 closed at a record 7,022.95 and the Nasdaq at 24,016.02 on Wednesday, erasing losses from the March selloff tied to the Feb. 28 conflict. Bank of America reported $8.6 billion in first-quarter net income, up 17%, while Morgan Stanley posted record revenue. Talks between Washington and Tehran raised hopes for easing oil supply fears, but Brent crude stayed elevated at $94.93 a barrel.
Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

16 April 2026
China is considering export restrictions on advanced solar-manufacturing equipment to the U.S., potentially affecting Tesla’s plans for new factories, sources told Reuters. Tesla aims to buy $2.9 billion in solar-panel equipment from China and expand U.S. solar production. China produces over 80% of global solar panel components. No final decision has been made, and consultations remain preliminary.
Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

15 April 2026
Hims & Hers Health shares rose 14% to $24.29 after the FDA said it will review restrictions on several peptides, including BPC-157 and TB-500. The agency set a July advisory meeting and will remove some peptides from its safety-risk list within a week. Hims, which acquired a California peptide facility last year, reported $2.35 billion in 2025 revenue and 2.511 million subscribers.
Commonwealth Bank of Australia share price slips as GDP data lifts RBA rate-hike nerves
Previous Story

Commonwealth Bank of Australia share price slips as GDP data lifts RBA rate-hike nerves

Wesfarmers share price slides to A$76 as ASX rout bites — what moved ASX:WES today
Next Story

Wesfarmers share price slides to A$76 as ASX rout bites — what moved ASX:WES today

Go toTop